VKH
SRNE

Virtu KCG Holdings’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Virtu KCG Holdings’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$328K Buy
163,931
+136,506
+498% +$266K 0.01% 1575
2017
Q1 		$108K Buy
+27,425
New +$138K ﹤0.01% 2664
2016
Q4 		– Sell
-21,653
Closed -$168K – 3915
2016
Q3 		$168K Buy
+21,653
New +$146K 0.01% 2456
2015
Q2 		– Sell
-12,995
Closed -$150K – 3892
2015
Q1 		$150K Buy
+12,995
New +$150K 0.01% 2527

Other funds holding SRNE

WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return